Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis
CD47 is a promising new target in cancer immunotherapy and recently the pro-phagocytic signal SLAMF7 has been shown to have a crucial role in phagocytosis induced by CD47-blocking antibody in hematological tumors. In this study, the authors demonstrate that SLAMF7 expressed by cancer cells is not re...
Guardado en:
Autores principales: | Yuan He, Renee Bouwstra, Valerie R. Wiersma, Mathilde de Jong, Harm Jan Lourens, Rudolf Fehrmann, Marco de Bruyn, Emanuele Ammatuna, Gerwin Huls, Tom van Meerten, Edwin Bremer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/69bb46c6cb07419c8c3da1b05f0247bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5
por: Lihi Radomir, et al.
Publicado: (2021) -
PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses
por: Song S, et al.
Publicado: (2019) -
HIV-1 Vpu Promotes Phagocytosis of Infected CD4<sup>+</sup> T Cells by Macrophages through Downregulation of CD47
por: Lijun Cong, et al.
Publicado: (2021) -
SLAMF7 and IL-6R define distinct cytotoxic versus helper memory CD8+ T cells
por: Lucie Loyal, et al.
Publicado: (2020) -
Acta No. 47
por: Banco Central de Chile
Publicado: (2019)